Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy

Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy

<p>Abstract</p> <p>Background</p> <p>The administration of rituximab (RTX) <it>in vivo </it>results in B-cell depletion, but evidence for multiple mechanisms of action have been reported. Surprisingly, B cell depletion produced a response in patients with po...

Full description

Bibliographic Details
Main Authors:	Porretti Laura, Bresolin Nereo, Belicchi Marzia, Marchesi Chiara, Cogiamanian Filippo, Lerario Alberto, Torrente Yvan
Format:	Article
Language:	English
Published:	BMC 2010-07-01
Series:	BMC Musculoskeletal Disorders
Online Access:	http://www.biomedcentral.com/1471-2474/11/157

Similar Items

Correlation of circulating CD133+ progenitor subclasses with a mild phenotype in Duchenne muscular dystrophy patients.
by: Chiara Marchesi, et al.
Published: (2008-05-01)

Gene-editing in patient and humanized-mice primary muscle stem cells rescues dysferlin expression in dysferlin-deficient muscular dystrophy
by: Helena Escobar, et al.
Published: (2025-01-01)

Editorial: Inflammation in muscular dystrophies: mediators, mechanisms, and therapeutics
by: Chiara Villa, et al.
Published: (2024-08-01)

Novel five nucleotide deletion in dysferlin leads to autosomal recessive limb‐girdle muscular dystrophy
by: Yen‐Lin Chen, et al.
Published: (2023-12-01)

The Immune System in Duchenne Muscular Dystrophy Pathogenesis
by: Luana Tripodi, et al.
Published: (2021-10-01)

Role of Immunoglobulins in Muscular Dystrophies and Inflammatory Myopathies
by: Andrea Farini, et al.
Published: (2021-07-01)

Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures
by: Lerario Alberto, et al.
Published: (2012-09-01)

Contribution of dysferlin deficiency to skeletal muscle pathology in asymptomatic and severe dystroglycanopathy models: generation of a new model for Fukuyama congenital muscular dystrophy.
by: Motoi Kanagawa, et al.
Published: (2014-01-01)

Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice
by: Zoe White, et al.
Published: (2022-11-01)

Full-length Dysferlin Transfer by the Hyperactive Sleeping Beauty Transposase Restores Dysferlin-deficient Muscle
by: Helena Escobar, et al.
Published: (2016-01-01)

Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy
by: Pamela Bella, et al.
Published: (2019-12-01)

Adhalin Deficiency in Muscular Dystrophy
by: J Gordon Millichap
Published: (1996-02-01)

Adhalin Deficiency and Muscular Dystrophy
by: J Gordon Millichap
Published: (1995-10-01)

Reprogramming of dermal fibroblasts from a Duchenne muscular dystrophy patient carrying a deletion of exons 45–50 into an induced pluripotent stem cell line (CCMi005-A)
by: Davide Rovina, et al.
Published: (2022-10-01)

Dysferlin-peptides reallocate mutated dysferlin thereby restoring function.
by: Verena Schoewel, et al.
Published: (2012-01-01)

Flavonoids and Omega3 Prevent Muscle and Cardiac Damage in Duchenne Muscular Dystrophy Animal Model
by: Luana Tripodi, et al.
Published: (2021-10-01)

Role of Insulin-Like Growth Factor Receptor 2 across Muscle Homeostasis: Implications for Treating Muscular Dystrophy
by: Yvan Torrente, et al.
Published: (2020-02-01)

Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c.1705-8 T>C.
by: Davide Rovina, et al.
Published: (2020-05-01)

Induction of Neurotrophin Expression via Human Adult Mesenchymal Stem Cells: Implication for Cell Therapy in Neurodegenerative Diseases
by: Federica Pisati, et al.
Published: (2007-01-01)

Insights into lipid accumulation in skeletal muscle in dysferlin-deficient mice
by: Anil K. Agarwal, et al.
Published: (2019-12-01)

Inhibition of the immunoproteasome modulates innate immunity to ameliorate muscle pathology of dysferlin-deficient BlAJ mice
by: A. Farini, et al.
Published: (2022-11-01)

Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy.
by: Eduard Gallardo, et al.
Published: (2011-01-01)

PTX3 Predicts Myocardial Damage and Fibrosis in Duchenne Muscular Dystrophy
by: Andrea Farini, et al.
Published: (2020-05-01)

Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies
by: Daniela Piga, et al.
Published: (2019-05-01)

Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice
by: Han Renzhi, et al.
Published: (2011-12-01)

Proper Voltage-Dependent Ion Channel Function in Dysferlin-Deficient Cardiomyocytes
by: Lena Rubi, et al.
Published: (2015-06-01)

Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy.
by: Metzinger, L, et al.
Published: (1997)

Alternative Sources of Neurons and Glia from Somatic Stem Cells
by: Yvan Torrente, et al.
Published: (2002-01-01)

Minimal expression of dysferlin prevents development of dysferlinopathy in dysferlin exon 40a knockout mice
by: Joe Yasa, et al.
Published: (2023-01-01)

Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes
by: Esther Fernández-Simón, et al.
Published: (2020-11-01)

Dysferlin deficiency alters lipid metabolism and remodels the skeletal muscle lipidome in mice
by: Vanessa R. Haynes, et al.
Published: (2019-08-01)

Feline dystrophin-deficient muscular dystrophy misdiagnosed as myositis
by: Rachel M Reynolds, et al.
Published: (2024-07-01)

Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021-06-01)

Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models.
by: Mary L Vallecillo-Zúniga, et al.
Published: (2020-01-01)

Effect of Dysferlin Deficiency on Atherosclerosis and Plasma Lipoprotein Composition Under Normal and Hyperlipidemic Conditions
by: Zoe White, et al.
Published: (2021-07-01)

Muscular Dystrophy /
by: Naff, Clay Farris, editor 192865, et al.
Published: (2012)

Glycogenin-1 deficiency mimicking limb-girdle muscular dystrophy
by: Claire Lefeuvre, et al.
Published: (2020-09-01)

MEROSIN-DEFICIENT CONGENITAL MUSCULAR DYSTROPHY (CMD1A): CLINICAL CASE OF CONGENITAL MUSCULAR DYSTROPHY INVOLVING CENTRAL NERVOUS SYSTEM
by: O. A. Klochkova, et al.
Published: (2014-07-01)

Distrofia muscular congênita e deficiência de merosina Congenital muscular dystrophy and merosin deficiency
by: Lineu Cesar Werneck, et al.
Published: (1997-01-01)

Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin‐deficient and mdx mice
by: Zoe White, et al.
Published: (2022-02-01)